Experimental effects of anti-arrhythmic drugs on ventricular fibrillation thresholds altered by regional hyperkalemia.
D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001949:Bretylium Compounds / Q000627:therapeutic use; D004285:Dogs; D004353:Drug Evaluation, Preclinical; D004562:Electrocardiography; D006947:Hyperkalemia / Q000503:physiopathology*; D008012:Lidocaine / Q000627:therapeutic use; D010672:Phenytoin / Q000627:therapeutic use; D011433:Propranolol / Q000627:therapeutic use; D013997:Time Factors; D014693:Ventricular Fibrillation / Q000188:drug therapy*
D000889:Anti-Arrhythmia Agents; D001949:Bretylium Compounds; D010672:Phenytoin; D008012:Lidocaine; D011433:Propranolol